Cargando…

Dietary Copper Reduces the Hepatotoxicity of (−)-Epigallocatechin-3-Gallate in Mice

We developed Cu-deficient, -sufficient and -super nutrition mice models by feeding them with diet containing 1.68, 11.72 or 51.69 mg of Cu/kg for 28 days, respectively. Then, the mice were treated to (−)-epigallocatechin-3-gallate (EGCG, 750 mg/kg BW) by oral in order to assess the acute toxicity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaleri, Najeeb Ahmed, Sun, Kang, Wang, Le, Li, Jin, Zhang, Wenzheng, Chen, Xuan, Li, Xinghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943924/ https://www.ncbi.nlm.nih.gov/pubmed/29295524 http://dx.doi.org/10.3390/molecules23010038

Ejemplares similares

Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity
por: Bulboacă, Adriana Elena, et al.
Publicado: (2022)

Epigallocatechin Gallate During Dietary Restriction — Potential Mechanisms of Enhanced Liver Injury
por: Shi, Zhuo, et al.
Publicado: (2021)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Paradoxical cardiotoxicity of intraperitoneally-injected epigallocatechin gallate preparation in diabetic mice
por: Rasheed, Nora O. Abdel, et al.
Publicado: (2018)

The protective effects of epigallocatechin gallate on lipopolysa ccharide-induced hepatotoxicity: an in vitro study on Hep3B cells
por: Karamese, Murat, et al.
Publicado: (2016)

The involvement of Nrf2 in the protective effects of (-)-Epigallocatechin-3-gallate (EGCG) on NaAsO(2)-induced hepatotoxicity
por: Han, Xiao-Dong, et al.
Publicado: (2017)

Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia
por: Ramachandran, Balaji, et al.
Publicado: (2016)

Epigallocatechin-3-Gallate Reduces Fat Accumulation in Caenorhabditis elegans
por: Liu, Jinning, et al.
Publicado: (2018)

Reducing the potential allergenicity of amandin through binding to (−)-epigallocatechin gallate
por: Luo, Xin, et al.
Publicado: (2022)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

The Effect of Ultrasound, Oxygen and Sunlight on the Stability of (−)-Epigallocatechin Gallate
por: Zeng, Jiajun, et al.
Publicado: (2018)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice
por: Lai, Yu-Heng, et al.
Publicado: (2018)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020)

Neuroprotective Activity of (−)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity
por: Liu, Jin-Biao, et al.
Publicado: (2016)

Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

In Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus
por: Zhao, Chunjian, et al.
Publicado: (2014)

Epigallocatechin-3-Gallate Reduces Cytotoxic Effects Caused by Dental Monomers: A Hypothesis
por: Jiao, Yang, et al.
Publicado: (2015)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro
por: Oliviero, Francesca, et al.
Publicado: (2013)

Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts
por: Salameh, Aida, et al.
Publicado: (2018)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
por: Li, Xiaoguang, et al.
Publicado: (2017)

Identification of the Catechin Uptake Transporter Responsible for Intestinal Absorption of Epigallocatechin Gallate in Mice
por: Ishii, Shunsuke, et al.
Publicado: (2019)

Antitumor Effect of Epigallocatechin Gallate and Vincristine in Mice with L5178Y Lymphoma
por: Almaguer, Georgina, et al.
Publicado: (2023)

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2016)

Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice
por: Yang, Xiu Hong, et al.
Publicado: (2016)

Epigallocatechin-3-gallate counters cisplatin toxicity of rat testes
por: Fouad, Amr A., et al.
Publicado: (2017)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise
por: Ahmed, Salahuddin
Publicado: (2010)

Bioaccessibility and Bioavailability of (-)-Epigallocatechin Gallate in the Bread Matrix with Glycemic Reduction
por: Li, Lanqi, et al.
Publicado: (2022)

Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation
por: Cione, Erika, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l4k3lgluhjfjndmo5li1jjmc3i